For research use only. Not for therapeutic Use.
FAAH-IN-2(Cat No.:I002388)is a selective inhibitor of fatty acid amide hydrolase (FAAH), an enzyme that degrades endocannabinoids like anandamide, which play a role in pain, mood, and neuroprotection. By inhibiting FAAH, FAAH-IN-2 increases the levels of endocannabinoids, enhancing their effects on the endocannabinoid system, which may lead to analgesic, anti-inflammatory, and anxiolytic benefits. Its specificity for FAAH makes it a valuable compound in research on pain management, anxiety, and neurodegenerative conditions, positioning FAAH-IN-2 as a promising tool in the development of endocannabinoid-based therapies.
Catalog Number | I002388 |
CAS Number | 184475-71-6 |
Molecular Formula | C15H11ClFN3O2 |
Purity | ≥95% |
Solubility | 10 mM in DMSO |
Storage | Store at -20°C |
IUPAC Name | 4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-ol |
InChI | InChI=1S/C15H11ClFN3O2/c1-22-14-6-12-9(5-13(14)21)15(19-7-18-12)20-8-2-3-11(17)10(16)4-8/h2-7,21H,1H3,(H,18,19,20) |
InChIKey | JLVTVCRXFMLUIF-UHFFFAOYSA-N |
SMILES | COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)O |
Reference | <p style=/line-height:25px/> |